Uric Acid, Heart Failure Survival, and the Impact of Xanthine Oxidase Inhibition
- 9 November 2011
- journal article
- review article
- Published by Wiley in Congestive Heart Failure
- Vol. 18 (3), 179-182
- https://doi.org/10.1111/j.1751-7133.2011.00262.x
Abstract
Increasing evidence suggests that serum uric acid (UA), a product of xanthine oxidase (XO), may be a useful marker for metabolic, hemodynamic, and functional staging in heart failure (HF) and a valid predictor of survival in HF patients. Recent data support an expanded role for UA and the XO pathway in the pathogenesis of HF, as studies have shown that an elevation in the enzymatic activity of XO can lead to increases in oxidative stress, endothelial dysfunction, and reduced myocardial function. Numerous population studies have previously reported that elevated UA levels are an independent predictor of cardiovascular mortality, and recent evidence suggests that lowering serum levels of UA may lead to improved outcomes in HF patients. The question of whether UA is only a marker rather than a causal factor in the pathogenesis of HF remains. Regardless of whether UA levels are ready for routine clinical use, either as a prognostic factor or novel therapeutic target, further prospective studies are necessary to demonstrate that routine measurement or reduction of UA levels improves outcomes in HF patients.Keywords
This publication has 46 references indexed in Scilit:
- Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: A Meta-AnalysisCongestive Heart Failure, 2011
- Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart FailureCirculation: Heart Failure, 2010
- Hyperuricemia in acute heart failure. More than a simple spectator?European Journal of Internal Medicine, 2009
- The association between serum uric acid level and long-term incidence of hypertension: population-based cohort studyJournal of Human Hypertension, 2006
- The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata StudyJournal of Cardiac Failure, 2006
- Uric Acid Is a Risk Factor for Myocardial Infarction and StrokeStroke, 2006
- Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated CardiomyopathyCirculation Research, 2006
- Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)The American Journal of Cardiology, 2005
- Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension IncidenceHypertension, 2005
- Hyperuricemia in Childhood Primary HypertensionHypertension, 2003